Pangea Bio
Biotechnology Research in United Kingdom
Overview
Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.
Tagline
Novel Therapies for Central Nervous System Disorders
EMPLOYEES
11-50 employees
FOUNDED
2021
HQ
London
TYPE
Privately Held
Location
- Street
- —
- City
- London
- Region
- —
- Postal code
- —
- Country
- United Kingdom
Email patterns
See email patterns for Pangea Bio
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
pangeabio.com is the website of Pangea Bio.
What is the industry of the company?
Pangea Bio (pangeabio.com) is in the Biotechnology Research industry.
When was the company founded?
Pangea Bio (pangeabio.com) was founded in 2021.
How many employees does the company have?
Pangea Bio (pangeabio.com) has 11-50 employees.
What is the company type?
The company type of Pangea Bio (pangeabio.com) is Privately Held.
Where is the company headquartered?
Pangea Bio (pangeabio.com) is headquartered in London.
What is the address of the company?
The address of Pangea Bio (pangeabio.com) is London, United Kingdom.
What are the social media accounts of the company?
The social media account of Pangea Bio (pangeabio.com) is LinkedIn.
Social media